Hodgkin lymphomas
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Pharmacogenetic study in <span class="disease" id="18768784-0-25-42">Hodgkin lymphomas</span> reveals the impact of <span class="gene" id="18768784-0-65-71">UGT1A1</span> polymorphisms on patient prognosis.